Supplementary Figure 1 from Quantitative Chemical Proteomics Profiling Differentiates Erlotinib from Gefitinib in <i>EGFR</i> Wild-Type Non–Small Cell Lung Carcinoma Cell Lines

Abstract

PDF file - 60K, Schematic diagram of the experimental framework applied to perform label-free, quantitative chemical proteomics on erlotinib and gefitinib</p